弓形虫脉络膜视网膜炎1例_Chinese Journal of Ocular Fundus Diseases

Authors：

容卓葳 ^1,2 , 刘欣雨 ¹ , 刘泽浩 ¹ , 崔金利 ¹ , 潘艳超 ³ ,  林英 ¹

Corresponding author：

林英, Email: linying@gzzoc.com

Keywords：

弓形虫视网膜炎; 脉络膜视网膜炎; 眼内炎; 病例报告

DOI：

10.3760/cma.j.cn511434-20250421-00177

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

1.	Maenz M, Schlüter D, Liesenfeld O, et al. Ocular toxoplasmosis past, present and new aspects of an old disease[J]. Prog Retin Eye Res, 2014, 39: 77-106. DOI: 10.1016/j.preteyeres.2013.12.005.
2.	Holland GN. Ocular toxoplasmosis: a global reassessment[J]. Am J Ophthalmol, 2003, 136(6): 973-988. DOI: 10.1016/j.ajo.2003.09.040.
3.	Smith JR, Ashander LM, Arruda SL, et al. Pathogenesis of ocular toxoplasmosis[J/OL]. Prog Retin Eye Res, 2021, 81: 100882[2020-07-24]. https://pubmed.ncbi.nlm.nih.gov/32717377/. DOI: 10.1016/j.preteyeres.2020.100882.
4.	Miyagaki M, Zong Y, Yang M, et al. Ocular toxoplasmosis: advances in toxoplasma gondii biology, clinical manifestations, diagnostics, and therapy[J]. Pathogens, 2024, 13(10): 898. DOI: 10.3390/pathogens13100898.
5.	Garweg JG, Pleyer U. Treatment strategy in human ocular toxoplasmosis: why antibiotics have failed[J/OL]. J Clin Med, 2021, 10(5): 1090[2021-03-05]. https://pubmed.ncbi.nlm.nih.gov/33807871/. DOI: 10.3390/jcm10051090.
6.	Dunay IR, Gajurel K, Dhakal R, et al. Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice[J/OL]. Clin Microbiol Rev, 2018, 31(4): e57-e67[2018-09-12]. https://pubmed.ncbi.nlm.nih.gov/30209035/. DOI: 10.1128/CMR.00057-17.

1. Maenz M, Schlüter D, Liesenfeld O, et al. Ocular toxoplasmosis past, present and new aspects of an old disease[J]. Prog Retin Eye Res, 2014, 39: 77-106. DOI: 10.1016/j.preteyeres.2013.12.005.
2. Holland GN. Ocular toxoplasmosis: a global reassessment[J]. Am J Ophthalmol, 2003, 136(6): 973-988. DOI: 10.1016/j.ajo.2003.09.040.
3. Smith JR, Ashander LM, Arruda SL, et al. Pathogenesis of ocular toxoplasmosis[J/OL]. Prog Retin Eye Res, 2021, 81: 100882[2020-07-24]. https://pubmed.ncbi.nlm.nih.gov/32717377/. DOI: 10.1016/j.preteyeres.2020.100882.
4. Miyagaki M, Zong Y, Yang M, et al. Ocular toxoplasmosis: advances in toxoplasma gondii biology, clinical manifestations, diagnostics, and therapy[J]. Pathogens, 2024, 13(10): 898. DOI: 10.3390/pathogens13100898.
5. Garweg JG, Pleyer U. Treatment strategy in human ocular toxoplasmosis: why antibiotics have failed[J/OL]. J Clin Med, 2021, 10(5): 1090[2021-03-05]. https://pubmed.ncbi.nlm.nih.gov/33807871/. DOI: 10.3390/jcm10051090.
6. Dunay IR, Gajurel K, Dhakal R, et al. Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice[J/OL]. Clin Microbiol Rev, 2018, 31(4): e57-e67[2018-09-12]. https://pubmed.ncbi.nlm.nih.gov/30209035/. DOI: 10.1128/CMR.00057-17.